A detailed history of Acadian Asset Management LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,556 shares of BLFS stock, worth $42,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,556
Holding current value
$42,058
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$19.19 - $26.52 $29,859 - $41,265
1,556 New
1,556 $38,000
Q1 2019

May 09, 2019

SELL
$10.9 - $21.26 $663,374 - $1.29 Million
-60,860 Closed
0 $0
Q4 2018

Feb 07, 2019

SELL
$9.5 - $17.17 $80,759 - $145,962
-8,501 Reduced 12.26%
60,860 $732,000
Q3 2018

Oct 30, 2018

BUY
$14.99 - $25.48 $291,645 - $495,738
19,456 Added 38.99%
69,361 $1.21 Million
Q2 2018

Jul 24, 2018

BUY
$6.18 - $13.49 $308,412 - $673,218
49,905 New
49,905 $569,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.15B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.